Higher Maintenance Cyclosporine Dose Decreases the Risk of Graft Failure in North American Children: A Report of the North American Pediatric Renal Transplant Cooperative Study

Journal of the American Society of Nephrology

Volumn 7, Issue 4, 1996, Pages 550-555

  Tejani, Amir ^a   Kenneth Sullivan, E ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Children; Cyclosporine dose; Graft failure

Indexed keywords

CYCLOSPORIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DONOR; DOSE RESPONSE; FOLLOW UP; GRAFT REJECTION; HUMAN; INFANT; KIDNEY TRANSPLANTATION; MULTICENTER STUDY; NORTH AMERICA; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INFANT; KIDNEY TRANSPLANTATION; NORTH AMERICA; TISSUE DONORS;

EID: 0030120516     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v74550     Document Type: Article

References (16)

1. Hoyer PF, Offner G, Wonigeit K, Brodehl J, Pichlmayr R: Dosage of Cyclosporin A in children with renal transplants. Clin Nephrol 1984;22:68-71.
2. McEnery PT, Alexander SR, Sullivan K, Tejani A: Renal transplantation in children and adolescents: The 1992 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1993;7: 711-720.
3. Grevel J, Kahan BD: In: Thompson AW, Ed. Sandimmun. Mode of Action and Clinical Application. Boston: Kluwer; 1986:252.
4. McEnery P, Arbus G, Stablein D, Tejani A: Renal transplantation in children. N Engl J Med 1992;326:1727-1732.
5. SAS Institute Inc. ®Language Reference, Version 6, 1st Ed. Cary, NC: SAS Institute Inc.; 1990.
6. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons; 1980.
7. Burke JF, Pirsch JD, Ramos EL, et al.: Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994;331:358-363.
8. Kahan BD, Kramer WG, Wideman CA, et al.: Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine. Transplant Proc 1986;18:115-119.
9. Hoppu K, Koskimies O, Holmbert C, Hirvisalo EL: Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol 1991;5:1-4.
10. Offner G, Hoyer PF, Ehrich JH, Pichlmary R, Brodehl J: Paediatric aspects of renal transplantation: Experience of a single centre. Eur J Pediatr 1992;151(Suppl 1):S16-S22.
11. Avner ED, Chavers B, Sullivan EK, Tejani A: Renal transplantation and chronic dialysis in children and adolescents: The 1993 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1995;9:61-73.
12. Hoyer PF, Offner G, Wonigeit K, Brodehl J, Pichlmayr R: Dosage of cyclosporine A in children with renal transplants. Clin Nephrol 1984;22:68-71.
13. Ettenger RB, Blifeld C, Prince H, et al.: The pediatric nephrologist's dilemma: Growth after renal transplantation and its interaction with age as a possible immunologic variable. J Pediatr 1987;111:1022-1025.
14. Salomon DR: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients. Transplant Proc 1991;23:2115-2118.
15. Almond PS, Matas A, Gillingham K, et al.: Risk factors for chronic rejection in renal allograft recipients. Transplantation 1994;55:752-757.
16. Harmon WE, Sullivan EK: Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation. Kidney Int 1993;44:S50-S55.